TVGN
Tevogen Bio Holdings IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$24.19M
P/E Ratio
—
EPS
$-8.08
Beta
-0.30
52W High
$75.50
52W Low
$4.13
50-Day MA
$10.36
200-Day MA
$30.26
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Tevogen Bio Holdings Inc
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. The company is headquartered in Warren, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-25.95M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -416.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-2.12 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 10.59 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.16M |
| Float | $1.06M |
| % Insiders | 74.79% |
| % Institutions | 2.54% |
Historical Volatility
HV 10-Day
121.13%
HV 20-Day
126.77%
HV 30-Day
143.09%
HV 60-Day
117.50%
HV Rank
100.0%
Volatility is currently contracting
Data last updated: 4/9/2026